Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-type lectin domain family 4 member G pseudogene 1 (CLEC4GP1)
- Target
- CLEC4GP1
- Molecular classification
- Pseudogene
01
Overview
C-type lectin domain family 4 member G pseudogene 1 (CLEC4GP1) is a human pseudogene, meaning it is genetically similar to protein-coding genes (such as C-type lectin family members) but does not produce a functional protein. Recent evidence suggests that CLEC4GP1 can affect trophoblast cell function through regulatory effects on mRNA stability, specifically altering cell viability, invasion, and apoptosis via modulation of IL-15 signaling. Its pathological relevance to preeclampsia has been described, but it is not a classical drug target such as a receptor or enzyme. Most genome databases do not attribute protein function, pathway role, or therapeutic targeting potential to CLEC4GP1
- Other names
- CLEC4GP1C-type lectin domain family 4, member G pseudogene 1
02
Mechanism of action
Not applicable. The gene does not encode a protein that is a drug target or effector
03
Biological functions
Potential gene regulationMay modulate cell apoptosis and invasion in specific trophoblast contextsNo confirmed protein function
04
Disease associations
Involvement in preeclampsia (modulates trophoblast cell viability and invasion through regulation of IL-15)Other roles remain unconfirmed or speculative
05
Biomarkers
Aberrant expression in placental tissue associated with preeclampsia
Beyond the preview
Go deeper on C-type lectin domain family 4 member G pseudogene 1 (CLEC4GP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on C-type lectin domain family 4 member G pseudogene 1 (CLEC4GP1).